4.3 Article

Vaccines to Prevent Pneumococcal Community - Acquired Pneumonia

Journal

CLINICS IN CHEST MEDICINE
Volume 39, Issue 4, Pages 733-+

Publisher

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.ccm.2018.07.007

Keywords

Streptococcus pneumoniae; Community-acquired pneumonia; Invasive pneumococcal disease; Pneumococcal vaccines; Pneumococcal conjugate vaccine; Pneumococcal polysaccharide vaccine

Funding

  1. Pfizer

Ask authors/readers for more resources

Streptococcus pneumoniae is the most frequent pathogen in community-acquired pneumonia and also causes invasive diseases like bacteremia and meningitis. Young children and elderly are especially at risk for pneumococcal diseases and are, therefore, eligible for pneumococcal vaccination in most countries. This reviews provides an overview of the current epidemiology of pneumococcal infections, history and evidence of available pneumococcal polysaccharide and conjugate vaccines, and current recommendations.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available